Connecticut prohibits harmful substance referred to as ‘gas station heroin’

Concerns Rise Over “Gas Station Heroin” as States Act Against Tianeptine

Medical professionals are increasingly alarmed by a substance known as “gas station heroin,” pushing several states to impose limitations or outright bans on tianeptine.

As of now, fourteen states have categorized this tricyclic antidepressant as a Schedule I controlled substance. Connecticut has just joined their ranks, prohibiting the sale and use of tianeptine starting Wednesday.

Health experts emphasize the dangers associated with this substance, which the U.S. Food and Drug Administration warns can produce euphoric effects at high doses, potentially proving stronger than morphine and other addictive opioids.

Some countries have responded by restricting the prescription and distribution of tianeptine, updating labels to inform the public of its addictive risks.

The Drug Enforcement Administration has indicated that the misuse of tianeptine can lead to severe health issues, including respiratory failure, extreme sedation, and even death. It’s often marketed in various forms—tablets, powders, salts, and liquids—promoted as aids for pain, anxiety, or mental sharpness.

Common retail locations for these products include convenience stores, gas stations, vape shops, and various online platforms, often sold under names like Tianaa, ZaZa, Neptune’s Fix, Pegasus, and TD Red.

Connecticut’s Lieutenant Governor, Susan Bysiewicz, stated that the regulatory change is vital for tackling addiction. She highlighted concerns regarding misleading marketing strategies and appealing flavors that mislead consumers into thinking these products are safe.

In addition to tianeptine, Connecticut has classified several other substances, including kratom and various synthetic compounds, under its controls. Earlier in the month, FDA Commissioner Martin McQuarrie expressed deep concerns about what he deemed a “dangerous and growing health trend,” urging heightened awareness of the risks associated with tianeptine, particularly for young people.

Dr. Robert Schwaner, a vice president at Stony Brook Urgent Care, pointed out that the FDA has never approved tianeptine as a dietary supplement. He explained how its euphoric effects stem from serotonin activity, but at higher doses, it can dangerously stimulate opioid receptors, leading to respiratory issues and heart failure.

Schwaner believes this substance is indeed addictive and warrants national oversight. He remarked that, due to its interaction with opioid receptors, individuals may develop tolerance, which in turn heightens the risk of dependence.